EC
IONS icon

Elequin Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Elequin Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-208
Closed -$15.6K – 805
2026
Q1 		$15.6K Sell
208
-503
-71% -$39.7K ﹤0.01% 283
2025
Q4 		$56.2K Buy
+711
New +$53.5K ﹤0.01% 136
2025
Q1 		– Sell
-325
Closed -$11.4K – 475
2024
Q4 		$11.4K Sell
325
-112
-26% -$4.19K ﹤0.01% 307
2024
Q3 		$17.5K Buy
+437
New +$20.3K ﹤0.01% 191
2024
Q2 		– Sell
-474
Closed -$20.5K – 267
2024
Q1 		$20.5K Buy
+474
New +$22.6K ﹤0.01% 50
2022
Q3 		– Sell
-532
Closed -$20K – 614
2022
Q2 		$20K Buy
532
+172
+48% +$6.49K ﹤0.01% 193
2022
Q1 		$13K Buy
+360
New +$11.8K ﹤0.01% 151

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Elequin Capital's IONS Position: Q2 2026 in Review

Elequin Capital sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 208 shares — an estimated $15.6K sold.

Elequin Capital first reported a position in IONS in Q1 2022 and held it in 7 quarters. The position peaked at $56.2K in Q4 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Elequin Capital reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 208 Ionis Pharmaceuticals shares in Q2 2026, an estimated $15.6K.
  • Elequin Capital first reported a position in Ionis Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • Elequin Capital's Ionis Pharmaceuticals position peaked at $56.2K in Q4 2025.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.